{"id":"https://openalex.org/W2906826903","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.e17035","title":"Cetuximab plus cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.","display_name":"Cetuximab plus cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.","publication_year":2014,"publication_date":"2014-05-20","ids":{"openalex":"https://openalex.org/W2906826903","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.e17035","mag":"2906826903"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.15_suppl.e17035","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.e17035","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.e17035","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016906227","display_name":"Esma Kerboua","orcid":"https://orcid.org/0009-0004-4847-4958","observed_orcids":["https://orcid.org/0009-0004-4847-4958"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ESMA Kerboua","raw_affiliation_strings":["Pierre and marie curie center, Algiers, Algeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pierre and marie curie center, Algiers, Algeria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073110414","display_name":"N. Ben Lagha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nawel Lagha","raw_affiliation_strings":["Pierre and marie curie center, Algiers, Algeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pierre and marie curie center, Algiers, Algeria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112406726","display_name":"Ferdous Kara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ferdous Kara","raw_affiliation_strings":["Pierre and marie curie center, Algiers, Algeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pierre and marie curie center, Algiers, Algeria","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110914808","display_name":"Kamel Bouzid","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kamel Bouzid","raw_affiliation_strings":["Pierre and marie curie center, Algiers, Algeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pierre and marie curie center, Algiers, Algeria","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"15_suppl","first_page":"e17035","last_page":"e17035"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11669","display_name":"Head and Neck Surgical Oncology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":1.0},{"id":"https://openalex.org/keywords/recurrent-nasopharyngeal-carcinoma","display_name":"recurrent nasopharyngeal carcinoma","score":0.9610000252723694},{"id":"https://openalex.org/keywords/metastatic-nasopharyngeal-carcinoma","display_name":"metastatic nasopharyngeal carcinoma","score":1.0},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.8889999985694885},{"id":"https://openalex.org/keywords/platinum-refractory-disease","display_name":"platinum-refractory disease","score":0.8309999704360962},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.593999981880188},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5170000195503235},{"id":"https://openalex.org/keywords/skin-toxicity","display_name":"skin toxicity","score":0.7089999914169312},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9492270946502686},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9409948587417603},{"id":"https://openalex.org/C2778997737","wikidata":"https://www.wikidata.org/wiki/Q1693598","display_name":"Nasopharyngeal carcinoma","level":3,"score":0.6730871796607971},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.6211444139480591},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6138265132904053},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.6087819337844849},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6015380024909973},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5201483368873596},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.44754213094711304},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.42974019050598145},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.34643226861953735},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34317857027053833},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2784227132797241},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.1964641809463501}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.15_suppl.e17035","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.e17035","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.e17035","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2095617994","https://openalex.org/W2921138031","https://openalex.org/W2206800230","https://openalex.org/W3092526323","https://openalex.org/W2589719148","https://openalex.org/W2011587308","https://openalex.org/W2382476795","https://openalex.org/W2010972764","https://openalex.org/W2284582409","https://openalex.org/W2361990641"],"abstract_inverted_index":{"e17035":[0],"Background:":[1],"To":[2],"evaluate":[3],"efficacy":[4],"and":[5,105,113,135,201],"toxicity":[6],"of":[7,44,59,68,83,156],"cetuximab":[8],"plus":[9],"cisplatin":[10,197],"in":[11,27,110,189,194,206],"recurrent":[12,48,211],"or":[13,38,49,212],"metastatic":[14,50,213],"nasopharyngeal":[15],"carcinoma":[16],"(NPC)":[17],"after":[18,42],"previous":[19],"platinum":[20],"based":[21],"chemotherapy":[22,46],"Methods:":[23],"An":[24],"open-label,":[25],"single-arm":[26],"patients":[28,89,107,119,130,137,143,209],"with":[29,132,139,144,169,196,210,221],"epidermal":[30],"growth":[31],"factor":[32],"receptor\u2013expressing":[33],"NPC":[34,214],"who":[35,215],"progressed":[36],"on":[37],"within":[39],"12":[40],"months":[41,165,168,182],"termination":[43],"platinum-based":[45,222],"for":[47,121,148],"disease.":[51],"Cetuximab":[52,193],"was":[53,74,180],"administered":[54,75],"at":[55,172],"an":[56,152,202],"initial":[57],"dose":[58],"400":[60],"mg/m2":[61,70],"followed":[62],"by":[63],"every":[64,76],"two":[65,142],"weeks":[66,78],"doses":[67],"500":[69],"until":[71],"progression.":[72],"Cisplatin":[73],"3":[77,185],"up":[79],"to":[80,102,160,166],"a":[81,170],"maximum":[82],"04":[84],"cycles.":[85],"Results:":[86],"Thirty":[87],"five":[88],"were":[90,108,124],"enrolled":[91],"(29":[92],"males,":[93],"6":[94],"females;":[95],"median":[96,171,176],"age,":[97],"30":[98],"years;":[99],"range,":[100],"18":[101],"59":[103],"years),":[104],"all":[106],"included":[109],"the":[111,117],"intent-to-treat":[112],"safety":[114,204],"analyses.":[115],"Of":[116],"29":[118],"assessable":[120],"efficacy,":[122],"there":[123],"six":[125],"partial":[126],"responses":[127],"(20.6%),":[128],"thirteen":[129],"(44,8%)":[131],"stable":[133],"disease,":[134,141],"eight":[136],"(27.5%)":[138],"progressive":[140],"complete":[145],"response":[146,154],"(6.8%)":[147],"locoregional":[149],"reccurence,":[150],"giving":[151],"overall":[153,177],"rate":[155],"72.2%.":[157],"The":[158,175],"time":[159,179],"progression":[161],"is":[162],"between":[163],"03":[164],"16":[167],"7.5":[173],"months.":[174],"survival":[178],"5.2":[181],"(3-9months).":[183],"Grade":[184],"cutaneous":[186],"toxicities":[187],"occurred":[188],"2":[190],"patients.":[191],"Conclusions:":[192],"combination":[195],"demonstrates":[198],"clinical":[199],"activity":[200],"acceptable":[203],"profile":[205],"heavily":[207],"pretreated":[208],"had":[216],"previously":[217],"experienced":[218],"treatment":[219],"failure":[220],"therapy.":[223]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2019-01-11T00:00:00"}